Flowable Hemostats Market Size And Forecast 2026–2030: Trends Driving Industry Expansion

Flowable Hemostats Market Report

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Flowable Hemostats Market Size And Revenue Outlook Through 2030

The flowable hemostats market has experienced robust growth in recent years. This market is projected to expand from $1.02 billion in 2025 to reach $1.1 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 7.8%. Historically, this expansion can be linked to several factors, including an increase in surgical procedure volumes, the rising adoption of advanced surgical tools, the availability of gelatin-based hemostatic agents, the widening scope of specialty surgical disciplines, and enhanced surgeon awareness regarding flowable hemostats.

The flowable hemostats market size is projected to experience robust expansion over the coming years. This market is set to achieve a value of $1.47 billion by 2030, advancing at a compound annual growth rate (CAGR) of 7.5%. The anticipated growth throughout this period stems from several factors, including a heightened demand for more rapid bleeding control, an increasing emphasis on patient safety outcomes, the widening adoption of minimally invasive and robotic surgeries, ongoing innovation in bioresorbable materials, and their expanded application in emergency and trauma care. Significant trends expected during the forecast timeframe encompass the escalating utilization of flowable hemostats in intricate surgical procedures, a growing embrace of combination hemostatic products, the surging need for prompt hemostasis solutions, the broadening spectrum of minimally invasive surgical applications, and an intensified focus on biocompatible materials.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=80818005&type=smp&name=Flowable%20Hemostats%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

Flowable Hemostats Market Opportunity Drivers: What’s Unlocking New Revenue Potential?

The flowable hemostats market is anticipated to expand, driven by a rising count of surgical procedures. This surge in operations can be attributed to an aging populace needing more age-related interventions, alongside technological progress making surgical treatments safer and more accessible. Flowable hemostats prove highly beneficial during surgeries by effectively managing bleeding in hard-to-reach locations or when conventional techniques fall short. As an illustration, a report released in June 2024 by the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional non-governmental organization, indicated that in 2023, the combined total of surgical and non-surgical procedures increased by 3.4%, reaching 34.9 million, compared to the preceding year. Consequently, the expanding volume of surgical procedures is fueling the advancement of the flowable hemostats market.

Flowable Hemostats Market Segment Performance And Emerging Opportunities

The flowable hemostats market covered in this report is segmented –

1) By Product: Active Hemostats, Passive Hemostats, Combination Hemostats

2) By Material: Porcine Gelatin, Bovine Gelatin

3) By Application: General Surgery, Cardiac Surgery, Vascular Surgery, Neuro And Spine Surgery, Orthopedic Surgery, Other Applications

4) By End User: Hospital And Clinics, Ambulatory Surgery Centers

Subsegments:

1) By Active Hemostats: Fibrin Sealants, Thrombin-Based Hemostats, Collagen-Based Hemostats, Biodegradable Polymer Hemostats

2) By Passive Hemostats: Gauze-Based Hemostats, Sponges and Pads, Cellulose-Based Hemostats, Granule-Based Hemostats

3) By Combination Hemostats: Fibrinogen and Thrombin Combination Products, Collagen and Fibrin Combination Products, Synthetic Combination Hemostats, Bioresorbable Combination Hemostats

Flowable Hemostats Market Innovation Trends: What Developments Are Reshaping The Industry?

Leading companies in the flowable hemostats market are prioritizing the development of advanced hemostatic agents for surgery, such as no-swell technology, to address the evolving requirements of surgical procedures. No-swell technology describes a feature of a hemostatic agent that prevents it from absorbing liquids and expanding, making it ideal for surgical uses where swelling might lead to complications. For example, in January 2023, Medcura Inc., a US-based surgical technology platform, attained Food and Drug Administration (FDA) breakthrough device designation for its LifeGel flowable technology, which manages bleeding during operations where swelling cannot be tolerated. Medcura’s LifeGel stands as the sole flowable hemostatic gel specifically engineered to overcome issues related to hemostatic swelling. This absorbable agent does not expand since it is fully hydrated and prepared for immediate use, potentially lessening risks associated with swelling, including nerve injury and paralysis. It is also economical, maintains antimicrobial characteristics, appears relatively transparent, and strongly adheres to tissues, thereby presenting a safer and more efficient solution for controlling blood loss in complex surgical interventions.

Flowable Hemostats Market Key Players: Which Companies Lead Industry Competition?

Major companies operating in the flowable hemostats market are Pfizer Inc., Johnson & Johnson Services Inc., Medtronic plc, Medline Industries Inc., Stryker Corporation, Baxter International Inc., B Braun Melsungen AG, Becton Dickinson and Company, Cook Medical Inc., Teleflex Incorporated, Mallinckrodt Pharmaceuticals, Integra LifeSciences Holdings Corporation, Gelita Medical GmbH, Ferrosan Medical Devices A/S, Marine Polymer Technologies Inc, Axio Biosolutions Private Limited, Hemostasis LLC, Aegis Lifesciences Private Limited, Medcura Health Inc, Arch Therapeutics Inc., Starch Medical Inc.

View The Full Flowable Hemostats Market Report:

https://thebusinessresearchcompany.com/report/flowable-hemostats-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

Flowable Hemostats Market Geographic Analysis: Where Is Demand Rising Fastest?

North America was the largest region in the flowable hemostats market in 2025. The regions covered in the flowable hemostats market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model